Cargando…
Universal Patient Identifier and Interoperability for Detection of Serious Drug Interactions: Retrospective Study
BACKGROUND: The United States, unlike other high-income countries, currently has no national unique patient identifier to facilitate health information exchange. Because of security and privacy concerns, Congress, in 1998, prevented the government from promulgating a unique patient identifier. The H...
Autores principales: | Sragow, Howard Michael, Bidell, Eileen, Mager, Douglas, Grannis, Shaun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718096/ https://www.ncbi.nlm.nih.gov/pubmed/33216009 http://dx.doi.org/10.2196/23353 |
Ejemplares similares
-
Patient-Centered Data Home: A Path Towards National Interoperability
por: Williams, Karmen S., et al.
Publicado: (2022) -
Towards Interoperability for Public Health Surveillance: Experiences from Two States
por: Dixon, Brian E., et al.
Publicado: (2013) -
Shared Interoperable Clinical Decision Support Service for Drug-Allergy Interaction Checks: Implementation Study
por: Jung, Sungwon, et al.
Publicado: (2022) -
Architecture for interoperable software in biology
por: Bare, James Christopher, et al.
Publicado: (2014) -
Grid interoperability: the interoperations cookbook
por: Field, L, et al.
Publicado: (2008)